Home
Solvias

Solvias Market Share Analysis for November 2025

Solvias is the global cGMP contract research organization (CRO) with a comprehensive portfolio of analytical services to advance your path to commercialization.

Science and Education > Chemistry

Domainsolvias.com

Year Founded1999

Employees501 - 1000

Annual Revenue$100M - $200M

Solvias

Solvias (including company regionals)

solvias.com

See more website traffic and engagement information

Solvias Revenue up to November 2025 is 100M - 200M

revenue generated by Solvias top domains

Solvias top domains revenue over 3 years

Revenue for Solvias top domains

solvias.com100M - 200M

See more with Sales Intelligence

Total visits to Solvias's top domains

Understand Solvias market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

solvias.com23.6K

See more with Sales Intelligence

Avg. visit duration in Solvias's top domains

Analyze Solvias engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

solvias.com00:00:28

See more with Sales Intelligence

Avg. pageviews on Solvias's top domains

See how Solvias keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

solvias.com1.61

See more with Sales Intelligence

Solvias top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Solvias

These are the website technologies, by industry, used by Solvias top domains

Advertising (10)

Google Adsense

Widget (6)

Twemoji

Conversion & Analytics (4)

Google Analytics

Audio Video Media (2)

YouTube

More Technologies

11

See all

News & Signals from Solvias

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSolvias Group expands facilities to United States.The new facility expanded Solvias' global network to six centers of excellence, established a second hub in the U.S. in a growing biotech hub, and reinforced its commitment to advancing transformative therapies for cancer and rare diseases.

NewsSolvias Group launched ESG initiative on Jan 1st '24.Since launching the ESG initiative in 2024, Solvias has made significant progress in building a strong sustainability framework.

NewsSolvias Group is developing test methods that are critical for the final release of patients' own edited cells.Solvias and Vertex Pharmaceuticals have worked together for several years to develop and validate test methods that are critical for the final release of patients' own edited cells, so that they can be delivered back to patients.